Renal cell cancer, the most common type of kidney cancer, develops in the lining of the kidney tubules. Several drugs are being studied to treat the cancer as a single agent or in combination with other anti-tumor drugs. Now, a phase I trial has reported the safety and efficacy of the combination treatment involving temsirolimus
The rest is here:
Temsirolimus-Bryostatin Combination found Safe and Effective against Metastatic Renal Cell Cancer
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.